Dz of prostate Flashcards
what is LUTs
lower urinary tract symptoms
effects 15-50% of men >40yo
pt impact increased risk of falls, decreased QOL, depression and Impaired ADL
causes of LUTS
dysfuntion of bladder, prostate
neurologic dz
medical condition
medications
normal bladder function
stores 300-500ml of urine
empties to completion after urge
abnormal function (failure to store)
voiding small amounts frequently
uncontrollable urge
incomplete emptying
function of prostate gland
Secretes prostatic fluid that is a thin, milky substance w/ an alkaline pH
overactive bladder syndrome
syndrome including urinary urgency w or w/o incontinence and urinary freq and noctura
BPH
asymptomatic microscopic detection of prostatic hyperplasia, the benign proliferation of the prostate stoma and epithelium
LUTS storage issues
urgency frequency noctuira urge incontinence stress incontinence overflow incontinence
LUTs voiding
hesitancy poor flow/weak stream intermittency straining to void terminal dribbling prolonged urination urinary retention
how to determine cause of symptoms
weak flow think prostate
voiding small amounts think bladder
good flow, norm volume thing other medical conditions
take home message about OAB and BPH
40-50% of men have coexisting symptoms
OAB tx
anticholinergics, antimuscarinic
bladder training, biofeedback, pelvic floor muscle therapy, electrical stimulation
surgical if necessary
OAB tx guidelines by AUA/SUFU
1st line: behavioral therapy and +/- pharmacologic therapy
2nd line: anticholingergics antimuscarinics
3rd line: surgery
OAB pharmacologic agents
Solifenacin
Oxybutinin
Fesoterodine
Tolterodine
BPH
MC benign tumor in men
genetic componenet
incidence increased w/age reaching 90% by 70’s
BPH patho
characterized by proliferation of prostate dihydrotestosterone (DHT) is the major hormone responsible for DHT
BPH s/s
obstructive/ irritative symptoms
chronic obstruction predisposes to recurrent UTI
Acute urinary bladder obstruction
BPH PE
complete GU/GI
prostate exam: comment on the size and consistency of gland thought this does not correlate to severity of symptoms
neuro exam
BPH labs
U/A exclude infection and hematuria: normal
PSA- used when screening for prostate CA in combo with DRE
use is controversial
BPH imaging
CT or Renal U/S only if there is presence of other urinary tract dz or complications of UTI
Cystoscopy only if considering surgery to help determine what approach to use
BPH tx
based on severity of dz
watchful waiting reserved for pts with mild dz and UAS score 0-7
medical therapy
surgery
BPH medical therapy
alpha blockers
a-1 blockers
a-2 blockers
5α-reductase inhibitors
alpha blockers MOA
relax smooth muscle in the bladder neck and prostate gland reducing bladder outlet obstruction and increasing peak urinary flow rates
alpha 1 blockers
requires dose titration
S/E: orthostatic hypoHTN, dizziness, fatigue, ejaculation, rhinitis
Ex: terazosin, Doxazosin, Prazosin
alpha 1a blockers
receptors are localized to prostate and bladder neck therefore fewer side effects
Ex: Tamsulosin, Silodosin
5α-reductase inhibitors MOA
MOA blocks the conversion of testosterone to dihydrotestosterone
decreases prostate size
reduces baseline PSa 50%